Animal models for AML, MDS and MPN

被引：0
|
作者：
Kitamura, Toshio [1 ]
机构：
[1] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Div Cellular Therapy, Tokyo 1138654, Japan
来源：
JOURNAL OF GENE MEDICINE | 2014年 / 16卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
E-3
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [21] 5q Deletions in MDS and MPN: The Accompanying Molecular Mutations Determine the Phenotype but TP53 Is Frequently Mutated in All Entities: MPN, MDS and MPN/MDS Overlap
    Haferlach, Claudia
    Meggendorfer, Manja
    Schnittger, Susanne
    Zenger, Melanie
    Kern, Wolfgang
    Haferlach, Torsten
    BLOOD, 2014, 124 (21)
  • [22] An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T
    Talati, Chetasi
    Padron, Eric
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) : 425 - 433
  • [23] An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T
    Chetasi Talati
    Eric Padron
    Current Hematologic Malignancy Reports, 2016, 11 : 425 - 433
  • [24] Multilineage Dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: A comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC)
    Haferlach, T.
    Miesner, M.
    Bacher, U.
    Weiss, T.
    Macijewski, K.
    Kohlmann, A.
    Klein, H-U
    Dugas, M.
    Kern, W.
    Schnittger, S.
    Haferlach, C.
    ONKOLOGIE, 2010, 33 : 8 - 8
  • [25] Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC)
    Miesner, Miriam
    Haferlach, Claudia
    Bacher, Ulrike
    Weiss, Tamara
    Macijewski, Katja
    Kohlmann, Alexander
    Klein, Hans-Ulrich
    Dugas, Martin
    Kern, Wolfgang
    Schnittger, Susanne
    Haferlach, Torsten
    BLOOD, 2010, 116 (15) : 2742 - 2751
  • [26] A Clinicopathologic Study of RUNX1 Mutated MDS and MDS/MPN
    Aqil, Barina
    Sukhanova, Madina
    Jennings, Lawrence
    Gao, Juehua
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1251 - 1251
  • [27] A Clinicopathologic Study of RUNX1 Mutated MDS and MDS/MPN
    Aqil, Barina
    Sukhanova, Madina
    Jennings, Lawrence
    Gao, Juehua
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1251 - 1251
  • [28] Magrolimab in MDS and AML
    Cookson, Emma
    LANCET HAEMATOLOGY, 2020, 7 (07): : E505 - E505
  • [29] MDS PROGRESSION TO AML
    Murray, Cindy
    LEUKEMIA RESEARCH, 2021, 108 : S60 - S60
  • [30] MDS and MPN as a continuum within myeloid neoplasms?
    Hofmann, W. K.
    Luebke, J.
    Streuer, A.
    Reiter, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 50 - 50
12345